| Financial Ratios | 2025-06-30 | 2024-09-30 |
|---|---|---|
| Return on Equity | -13.5 | - |
| Net Profit Margin | -157.23 | -774.653 |
| Debt to Asset Ratio | 12.812 | - |
| Cash Ratio | 151.174 | - |
| Quick Ratio | 916.368 | - |
| Current Ratio | 916.368 | - |
Sage Therapeutics, Inc. (SAGE)
Sage Therapeutics, Inc. (SAGE)